• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏指数及其与肝癌侵袭性指标的关系。

A Liver Index and its Relationship to Indices of HCC Aggressiveness.

作者信息

Carr Brian I, Guerra Vito, Giannini Edoardo G, Farinati Fabio, Ciccarese Francesca, Rapaccini Gian Ludovico, Di Marco Maria, Benvegnù Luisa, Zoli Marco, Borzio Franco, Caturelli Eugenio, Masotto Alberto, Trevisani Franco

机构信息

Izmir Biomedicine and Genome Center, Dokuz Eylul University, Turkey and Lusaka Apex Medical University, Zambia.

Department of Clinical Trials and Epidemiology, IRCCS de Bellis, Castellana Grotte, Italy.

出版信息

J Integr Oncol. 2016 Oct;5(4). doi: 10.4172/2329-6771.1000178. Epub 2016 Sep 5.

DOI:10.4172/2329-6771.1000178
PMID:28580457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5450974/
Abstract

A Hepatocellular (HCC) Aggressiveness Index was recently constructed, consisting of the sum of the scores for the 4 clinical parameters of maximum tumor size, multifocality, presence of portal vein thrombus and blood alphafetoprotein levels. It was observed that there was an association with several liver function tests. We have now formed a Liver Index from the 4 liver parameters with the highest hazard ratios with respect to HCC aggressiveness, namely: blood total bilirubin, gamma glutamyl transpeptidase (GGTP), albumin and platelet levels (cirrhosis surrogate). We found that the scores for the Liver Index related significantly to survival, but also to the Aggressiveness Index and to its individual HCC components as well as showing significant trends with the components. These results support the hypothesis that liver function is not only an important prognostic factor in HCC patients, but may also be involved in HCC biology and aggressiveness. Blood albumin, GGTP, albumin and platelet levels were used to create a Liver Index that related significantly to parameters of HCC aggressiveness.

摘要

最近构建了一个肝细胞癌(HCC)侵袭性指数,它由最大肿瘤大小、多灶性、门静脉血栓形成和血液甲胎蛋白水平这4个临床参数的得分总和组成。据观察,它与多项肝功能检查存在关联。我们现在根据与HCC侵袭性具有最高风险比的4个肝脏参数形成了一个肝脏指数,即:血液总胆红素、γ-谷氨酰转肽酶(GGTP)、白蛋白和血小板水平(肝硬化替代指标)。我们发现肝脏指数得分与生存率显著相关,也与侵袭性指数及其各个HCC组成部分显著相关,并且与这些组成部分呈现出显著趋势。这些结果支持了这样一种假说,即肝功能不仅是HCC患者的一个重要预后因素,而且可能还参与了HCC的生物学特性和侵袭性。血液白蛋白、GGTP、白蛋白和血小板水平被用于创建一个与HCC侵袭性参数显著相关的肝脏指数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bba/5450974/259c9eb7775d/nihms861810f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bba/5450974/cc119970481b/nihms861810f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bba/5450974/259c9eb7775d/nihms861810f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bba/5450974/cc119970481b/nihms861810f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bba/5450974/259c9eb7775d/nihms861810f2.jpg

相似文献

1
A Liver Index and its Relationship to Indices of HCC Aggressiveness.肝脏指数及其与肝癌侵袭性指标的关系。
J Integr Oncol. 2016 Oct;5(4). doi: 10.4172/2329-6771.1000178. Epub 2016 Sep 5.
2
Validation of a Liver Index and Its Significance for HCC Aggressiveness.一种肝脏指数的验证及其对肝癌侵袭性的意义
J Gastrointest Cancer. 2017 Sep;48(3):262-266. doi: 10.1007/s12029-017-9971-4.
3
A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.一种肝细胞癌侵袭性指数及其与肝酶水平的关系。
Oncology. 2016;90(4):215-20. doi: 10.1159/000444394. Epub 2016 Mar 15.
4
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.血浆胆红素异常与侵袭性肝细胞癌表型相关。
Semin Oncol. 2014 Apr;41(2):252-8. doi: 10.1053/j.seminoncol.2014.03.006. Epub 2014 Mar 6.
5
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.分析经肝动脉化疗栓塞治疗的肝细胞癌患者的侵袭性因素。
World J Gastroenterol. 2018 Apr 21;24(15):1641-1649. doi: 10.3748/wjg.v24.i15.1641.
6
Significance of platelet and AFP levels and liver function parameters for HCC size and survival.血小板、甲胎蛋白水平及肝功能参数对肝癌大小和生存的意义。
Int J Biol Markers. 2014 Sep 30;29(3):e215-23. doi: 10.5301/jbm.5000064.
7
Low alpha-fetoprotein HCC and the role of GGTP.低甲胎蛋白肝癌与γ-谷氨酰转肽酶的作用
Int J Biol Markers. 2014 Dec 9;29(4):e395-402. doi: 10.5301/jbm.5000092.
8
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.血清γ-谷氨酰转肽酶水平与肝癌人类生物学及预后的关系。
J Transl Sci. 2021 Jun;7(3). doi: 10.15761/jts.1000446. Epub 2020 Sep 17.
9
Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.肝癌大小:血小板、γ-谷氨酰转肽酶和碱性磷酸酶。
Oncology. 2013;85(3):153-9. doi: 10.1159/000354416. Epub 2013 Aug 29.
10
Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.肝细胞癌患者血清白蛋白水平与肿瘤参数的关系
Int J Biol Markers. 2017 Oct 31;32(4):e391-e396. doi: 10.5301/ijbm.5000300.

引用本文的文献

1
Serum CYFRA 21-1 and CK19-2G2 as Predictive Biomarkers of Response to Transarterial Chemoembolization in Hepatitis C-related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.血清细胞角蛋白片段21-1和细胞角蛋白19-2G2作为埃及丙型肝炎相关肝细胞癌经动脉化疗栓塞反应的预测生物标志物:一项前瞻性研究。
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102405. doi: 10.1016/j.jceh.2024.102405. Epub 2024 Aug 17.
2
Alpha-fetoprotein and albumin inversely relate to each other and to tumor parameters in patients with hepatocellular carcinoma.在肝细胞癌患者中,甲胎蛋白和白蛋白相互呈负相关,且与肿瘤参数也呈负相关。
Hepatol Forum. 2024 Jan 16;5(1):11-17. doi: 10.14744/hf.2023.2023.0023. eCollection 2024.
3

本文引用的文献

1
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.提出并验证了一种新的模型,用于估计肝癌患者的生存情况。
Eur J Cancer. 2016 Aug;63:25-33. doi: 10.1016/j.ejca.2016.04.023. Epub 2016 May 31.
2
A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.一种肝细胞癌侵袭性指数及其与肝酶水平的关系。
Oncology. 2016;90(4):215-20. doi: 10.1159/000444394. Epub 2016 Mar 15.
3
Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level.
肝细胞癌侵袭性特征之间的不一致性:门静脉血栓形成和多灶性,与肿瘤大小有关,但与血清甲胎蛋白水平无关。
Liver Res. 2023 Sep;7(3):256-262. doi: 10.1016/j.livres.2023.07.003. Epub 2023 Jul 16.
4
Modulation of the Tumor Microenvironment by Ellagic Acid in Rat Model for Hepatocellular Carcinoma: A Potential Target against Hepatic Cancer Stem Cells.大鼠肝细胞癌模型中鞣花酸对肿瘤微环境的调节作用:对抗肝癌干细胞的潜在靶点
Cancers (Basel). 2023 Oct 9;15(19):4891. doi: 10.3390/cancers15194891.
5
The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis.血清内脂素和内脏脂肪素在丙型肝炎相关肝硬化肝细胞癌中的作用
Clin Exp Hepatol. 2023 Sep;9(3):210-220. doi: 10.5114/ceh.2023.130499. Epub 2023 Aug 24.
6
Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin.索磷布韦、达卡他韦、聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎患者中TP53基因的转录分析
ACS Omega. 2023 Apr 11;8(16):14784-14791. doi: 10.1021/acsomega.3c00903. eCollection 2023 Apr 25.
7
May an aspirin a day truly take hepatocellular carcinoma away?每日一片阿司匹林真的能远离肝细胞癌吗?
Ann Transl Med. 2023 Mar 15;11(5):225. doi: 10.21037/atm-22-6434. Epub 2023 Jan 16.
8
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders.阿司匹林对接受索拉非尼治疗的肝细胞癌患者的有益预后影响:一个关于多个混杂因素的故事
Cancers (Basel). 2021 Dec 20;13(24):6376. doi: 10.3390/cancers13246376.
9
Bi-Functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma.双功能肽作为肝细胞癌的一种新型治疗工具
Pharmaceutics. 2021 Oct 6;13(10):1631. doi: 10.3390/pharmaceutics13101631.
10
Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.肝癌侵袭性指标的相关性研究。
J Gastrointest Cancer. 2021 Dec;52(4):1340-1349. doi: 10.1007/s12029-021-00720-z. Epub 2021 Oct 6.
将白蛋白-胆红素(ALBI)评分纳入巴塞罗那临床肝癌(BCLC)系统用于肝细胞癌。
J Gastroenterol Hepatol. 2016 Jul;31(7):1300-6. doi: 10.1111/jgh.13291.
4
Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC.肝癌中微环境血小板因子对多激酶抑制剂敏感性和耐药性的调节作用
Expert Opin Pharmacother. 2015;16(18):2773-80. doi: 10.1517/14656566.2015.1101065. Epub 2015 Oct 19.
5
Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.肝细胞癌的肿瘤标志物:肝癌患者预后的简单且重要的预测指标
Liver Cancer. 2015 Mar;4(2):126-36. doi: 10.1159/000367735.
6
Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.评估与中国肝细胞癌患者总生存期相关的八种不同临床分期系统。
Chin Med J (Engl). 2015 Feb 5;128(3):316-21. doi: 10.4103/0366-6999.150095.
7
Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.基于γ-谷氨酰转移酶和碱性磷酸酶的肝细胞癌预后模型。
World J Gastroenterol. 2014 Aug 21;20(31):10944-52. doi: 10.3748/wjg.v20.i31.10944.
8
Platelet-related phenotypic patterns in hepatocellular carcinoma patients.肝细胞癌患者血小板相关表型模式
Semin Oncol. 2014 Jun;41(3):415-21. doi: 10.1053/j.seminoncol.2014.04.001. Epub 2014 Apr 23.
9
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.血小板因子对肝癌细胞系中索拉非尼和瑞戈非尼作用的拮抗作用
BMC Cancer. 2014 May 21;14:351. doi: 10.1186/1471-2407-14-351.
10
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.血浆胆红素异常与侵袭性肝细胞癌表型相关。
Semin Oncol. 2014 Apr;41(2):252-8. doi: 10.1053/j.seminoncol.2014.03.006. Epub 2014 Mar 6.